{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:06:51Z","timestamp":1784099211105,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-026-01424-x","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:14:25Z","timestamp":1784096065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic investigation of TRIB3-mediated growth, metastasis and ferroptosis in renal cell carcinoma"],"prefix":"10.1007","volume":"39","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"1424_CR1","doi-asserted-by":"publisher","DOI":"10.1172\/jci178915","author":"P Barata","year":"2024","unstructured":"Barata P, Gulati S, Elliott A, Hammers HJ, Burgess E, Gartrell BA, et al. Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/jci178915.","journal-title":"J Clin Invest"},{"key":"1424_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.954264","volume":"10","author":"H Wang","year":"2022","unstructured":"Wang H, Wang Y, Li L, Zhou H, Lili S, Li L, et al. Economic evaluation of first-line nivolumab plus cabozantinib for advanced renal cell carcinoma in China. Front Public Health. 2022;10:954264. https:\/\/doi.org\/10.3389\/fpubh.2022.954264.","journal-title":"Front Public Health"},{"issue":"3","key":"1424_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41585-022-00676-0","volume":"20","author":"M Rosellini","year":"2023","unstructured":"Rosellini M, Marchetti A, Mollica V, Rizzo A, Santoni M, Massari F. Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma. Nat Rev Urol. 2023;20(3):133\u201357. https:\/\/doi.org\/10.1038\/s41585-022-00676-0.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun DA, Bakouny Z, Hirsch L, Flippot R, Van Allen EM, Wu CJ, et al. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat Rev Clin Oncol. 2021;18(4):199\u2013214. https:\/\/doi.org\/10.1038\/s41571-020-00455-z.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"1424_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri TK, Motzer RJ. Systemic therapy for metastatic renal-cell carcinoma. N Engl J Med. 2017;376(4):354\u201366. https:\/\/doi.org\/10.1056\/NEJMra1601333.","journal-title":"N Engl J Med"},{"issue":"2","key":"1424_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lddd.2025.100013","volume":"22","author":"R Luo","year":"2025","unstructured":"Luo R, Li S, Wang H, Zhang Z, Li L, Shang P. Thymoquinone suppresses cell growth and induces ferroptosis in renal cell carcinoma by reducing SERPINH1 expression. Lett Drug Des Discov. 2025;22(2):100013. https:\/\/doi.org\/10.1016\/j.lddd.2025.100013.","journal-title":"Lett Drug Des Discov"},{"issue":"8","key":"1424_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/carcin\/bgae042","volume":"45","author":"S Lei","year":"2024","unstructured":"Lei S, Sun J, Xie Y, Xiao X, He X, Lin S, et al. Diverse functions of Tribbles homolog 3 in cancers and its potential as a therapeutic target. Carcinogenesis. 2024;45(8):527\u201342. https:\/\/doi.org\/10.1093\/carcin\/bgae042.","journal-title":"Carcinogenesis"},{"key":"1424_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2024.105977","volume":"164","author":"Z Meng","year":"2024","unstructured":"Meng Z, Wang Y, Wang X, Han X. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK\/JUN-mediated aerobic glycolysis. Arch Oral Biol. 2024;164:105977. https:\/\/doi.org\/10.1016\/j.archoralbio.2024.105977.","journal-title":"Arch Oral Biol"},{"issue":"1","key":"1424_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00503-9","volume":"13","author":"G Gallo-Oller","year":"2024","unstructured":"Gallo-Oller G, Pons G, Sansa-Girona J, Navarro N, Zarzosa P, Garc\u00eda-Gilabert L, et al. TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma. Exp Hematol Oncol. 2024;13(1):38. https:\/\/doi.org\/10.1186\/s40164-024-00503-9.","journal-title":"Exp Hematol Oncol"},{"key":"1424_CR10","doi-asserted-by":"crossref","unstructured":"Wang F, He Z, Zhou L, Chen X, Chen X, Zhao Z et al. Molecular Basis of USP28 Allosteric Inhibition by Small-Molecule Inhibitor AZ1. 2024","DOI":"10.2139\/ssrn.4676302"},{"issue":"3","key":"1424_CR11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.7150\/ijbs.29737","volume":"15","author":"B Hong","year":"2019","unstructured":"Hong B, Zhou J, Ma K, Zhang J, Xie H, Zhang K, et al. TRIB3 promotes the proliferation and invasion of renal cell carcinoma cells via activating MAPK signaling pathway. Int J Biol Sci. 2019;15(3):587\u201397. https:\/\/doi.org\/10.7150\/ijbs.29737.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"1424_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s44321-025-00200-y","volume":"17","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Yang T, Yu X, Li B, Liu J, Mao Y, et al. Lanatoside C activates the E3 ligase STUB1 to inhibit FOXP3 transcriptional activity and promote antitumor immunity. EMBO Mol Med. 2025;17(3):563\u201388. https:\/\/doi.org\/10.1038\/s44321-025-00200-y.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1424_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53002-0","volume":"15","author":"H Rho","year":"2024","unstructured":"Rho H, Kim S, Kim SU, Kim JW, Lee SH, Park SH, et al. CHIP ameliorates nonalcoholic fatty liver disease via promoting K63- and K27-linked STX17 ubiquitination to facilitate autophagosome-lysosome fusion. Nat Commun. 2024;15(1):8519. https:\/\/doi.org\/10.1038\/s41467-024-53002-0.","journal-title":"Nat Commun"},{"issue":"1","key":"1424_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00523-4","volume":"13","author":"H Dong","year":"2024","unstructured":"Dong H, Jia W, Meng W, Zhang R, Qi Z, Chen Z, et al. DAB2IP inhibits glucose uptake by modulating HIF-1\u03b1 ubiquitination under hypoxia in breast cancer. Oncogenesis. 2024;13(1):20. https:\/\/doi.org\/10.1038\/s41389-024-00523-4.","journal-title":"Oncogenesis"},{"issue":"1","key":"1424_CR15","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s42003-024-07127-z","volume":"7","author":"L Zhao","year":"2024","unstructured":"Zhao L, Yang H, Wang Y, Yang S, Jiang Q, Tan J, et al. STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression. Commun Biol. 2024;7(1):1439. https:\/\/doi.org\/10.1038\/s42003-024-07127-z.","journal-title":"Commun Biol"},{"issue":"11","key":"1424_CR16","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1038\/s41418-020-0571-7","volume":"27","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li C, Li H, Yuan L, Dai H, Peng Z, et al. Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. Cell Death Differ. 2020;27(11):3177\u201395. https:\/\/doi.org\/10.1038\/s41418-020-0571-7.","journal-title":"Cell Death Differ"},{"issue":"10","key":"1424_CR17","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.2174\/1570180820666230519140242","volume":"21","author":"W Shi-Han","year":"2024","unstructured":"Shi-Han W, Yi-Yuan M, Li-Jin Y, Yu-Hao C, Zhen-Jiang T, Jia-Zhen W, et al. Scaffold-hopping of linifanib to design 6-phenylisoxazolo[3,4-b]pyridin-3-amine derivatives as FLT3 inhibitors for treating acute myeloid leukemia. Lett Drug Des Discov. 2024;21(10):1833\u201346. https:\/\/doi.org\/10.2174\/1570180820666230519140242.","journal-title":"Lett Drug Des Discov"},{"issue":"1","key":"1424_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01359-7","volume":"22","author":"A Giannoudis","year":"2020","unstructured":"Giannoudis A, Malki MI, Rudraraju B, Mohhamed H, Menon S, Liloglou T, et al. Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer. Breast Cancer Res. 2020;22(1):126. https:\/\/doi.org\/10.1186\/s13058-020-01359-7.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"1424_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-025-03922-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li S, Xu Y, Chen Y, Xu C, He Q, et al. UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2. World J Surg Oncol. 2025;23(1):270. https:\/\/doi.org\/10.1186\/s12957-025-03922-y.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"1424_CR20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1177\/1947601910370700","volume":"1","author":"S Li","year":"2010","unstructured":"Li S, Ezhevsky S, Dewing A, Cato MH, Scortegagna M, Bhoumik A, et al. Radiation sensitivity and tumor susceptibility in ATM phospho-mutant ATF2 mice. Genes Cancer. 2010;1(4):316\u201330. https:\/\/doi.org\/10.1177\/1947601910370700.","journal-title":"Genes Cancer"},{"issue":"4","key":"1424_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mc.23868","volume":"64","author":"Z Lu","year":"2025","unstructured":"Lu Z, Xu J, Li J. The transcription factor ATF2 accelerates clear cell renal cell carcinoma progression through activating the PLEKHO1\/NUS1 pathway. Mol Carcinog. 2025;64(4):617\u201328. https:\/\/doi.org\/10.1002\/mc.23868.","journal-title":"Mol Carcinog"},{"issue":"12","key":"1424_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123207","volume":"15","author":"V Schiavoni","year":"2023","unstructured":"Schiavoni V, Campagna R, Pozzi V, Cecati M, Milanese G, Sartini D, et al. Recent advances in the management of clear cell renal cell carcinoma: novel biomarkers and targeted therapies. Cancers (Basel). 2023;15(12):3207. https:\/\/doi.org\/10.3390\/cancers15123207.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1424_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2174\/0109298665357331250416081850","volume":"32","author":"H Zixiong","year":"2025","unstructured":"Zixiong H, Yiqing D, Huaqi Y, Gongwei W, Tao X. Inhibition of canonical wnt signaling in renal cell carcinoma bone metastasis: an immunohistochemical analysis of DKK1 and LRP5 expression. Protein Pept Lett. 2025;32(5):327\u201334. https:\/\/doi.org\/10.2174\/0109298665357331250416081850.","journal-title":"Protein Pept Lett"},{"issue":"1","key":"1424_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02152-7","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu C, Yang Y, Ren H, Ren T, Huang Y, et al. TRIB3 inhibition by palbociclib sensitizes prostate cancer to ferroptosis via downregulating SOX2\/SLC7A11 expression. Cell Death Discov. 2024;10(1):425. https:\/\/doi.org\/10.1038\/s41420-024-02152-7.","journal-title":"Cell Death Discov"},{"issue":"3","key":"1424_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06472-5","volume":"15","author":"L Chen","year":"2024","unstructured":"Chen L, Lin W, Zhang H, Geng S, Le Z, Wan F, et al. TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis. Cell Death Dis. 2024;15(3):178. https:\/\/doi.org\/10.1038\/s41419-024-06472-5.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1424_CR26","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5009\/gnl240439","volume":"19","author":"J Wang","year":"2025","unstructured":"Wang J, Wu X. TEAD4 transcriptionally activates TRIB3 to induce ferroptosis resistance through the MEK\/ERK signaling pathway in colorectal cancer. Gut Liver. 2025;19(4):579\u201391. https:\/\/doi.org\/10.5009\/gnl240439.","journal-title":"Gut Liver"},{"issue":"5","key":"1424_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1424_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-021-00763-1","volume":"28","author":"HY Chen","year":"2021","unstructured":"Chen HY, Hsu CL, Lin HY, Lin YF, Tsai SF, Ho YJ, et al. Clinical and functional characterization of a novel STUB1 frameshift mutation in autosomal dominant spinocerebellar ataxia type 48 (SCA48). J Biomed Sci. 2021;28(1):65. https:\/\/doi.org\/10.1186\/s12929-021-00763-1.","journal-title":"J Biomed Sci"},{"issue":"1","key":"1424_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29442-x","volume":"13","author":"G Apriamashvili","year":"2022","unstructured":"Apriamashvili G, Vredevoogd DW, Krijgsman O, Bleijerveld OB, Ligtenberg MA, de Bruijn B, et al. Ubiquitin ligase STUB1 destabilizes IFN\u03b3-receptor complex to suppress tumor IFN\u03b3 signaling. Nat Commun. 2022;13(1):1923. https:\/\/doi.org\/10.1038\/s41467-022-29442-x.","journal-title":"Nat Commun"},{"issue":"4","key":"1424_CR30","doi-asserted-by":"publisher","first-page":"028","DOI":"10.1093\/pcmedi\/pbad028","volume":"6","author":"A Amarah","year":"2023","unstructured":"Amarah A, Elsabagh AA, Ouda A, Karen O, Ferih K, Elmakaty I, et al. Emerging roles of activating transcription factor 2 in the development of breast cancer: a comprehensive review. Precis Clin Med. 2023;6(4):028. https:\/\/doi.org\/10.1093\/pcmedi\/pbad028.","journal-title":"Precis Clin Med"},{"issue":"11","key":"1424_CR31","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1002\/hed.21648","volume":"33","author":"D Duffey","year":"2011","unstructured":"Duffey D, Dolgilevich S, Razzouk S, Li L, Green R, Gorti GK. Activating transcription factor-2 in survival mechanisms in head and neck carcinoma cells. Head Neck. 2011;33(11):1586\u201399. https:\/\/doi.org\/10.1002\/hed.21648.","journal-title":"Head Neck"},{"issue":"12","key":"1424_CR32","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1177\/1535370217701625","volume":"242","author":"X Sun","year":"2017","unstructured":"Sun X, Lou L, Zhong K, Wan L. MicroRNA-451 regulates chemoresistance in renal cell carcinoma by targeting ATF-2 gene. Exp Biol Med (Maywood). 2017;242(12):1299\u2013305. https:\/\/doi.org\/10.1177\/1535370217701625.","journal-title":"Exp Biol Med (Maywood)"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01424-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01424-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:14:27Z","timestamp":1784096067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01424-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01424-x","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in strict accordance with the relevant regulations and requirements of the Declaration of Helsinki. Written informed consents were obtained from all participants and this study was permitted by the Ethics Committee of Hebei Medical University Third Hospital (HDYY-LW-26062). The procedures performed on all animals complied with the standards formulated by the Experimental Animal Ethics Committee of Hebei Medical University Third Hospital and obtained the approval of the said committee (HDYY-LW-26062).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"108"}}